United States Securities and Exchange Commission v. Findley

CourtDistrict Court, D. Connecticut
DecidedFebruary 21, 2024
Docket3:20-cv-00397
StatusUnknown

This text of United States Securities and Exchange Commission v. Findley (United States Securities and Exchange Commission v. Findley) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States Securities and Exchange Commission v. Findley, (D. Conn. 2024).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION, No. 3:20-cv-0397 (SRU) Plaintiff,

v.

BERNARD FINDLEY and HALITRON, INC., Defendants.

MEMORANDUM OF DECISION AND PERMANENT INJUNCTION ORDER

Defendant Bernard Findley is the Chairman and CEO (and sole officer and director) of Defendant Halitron, Inc., an equity holding company based in Connecticut. In 2020, the Securities and Exchange Commission (“SEC”) charged Findley and Halitron (collectively “defendants”) with violations of Section 17(a) of the Securities Act, 15 U.S.C. § 77q(a), and Section 10(b) and Rule 10b-5 of the Exchange Act, 15 U.S.C. § 78j(b) and 17 C.F.R. § 240.10b-5. After a trial in January 2023, a jury found the defendants liable for publishing press releases containing fraudulent misrepresentations about the status of Halitron’s financial audit, a stock buyback program, and a $3 million promissory note from Life’s Time Capsule (“LTCP”). Before the Court now is the SEC’s motion for entry of final judgment, doc. no. 146, requesting that the Court impose remedies against Defendants Findley and Halitron, Inc. in the form of disgorgement, a civil penalty, permanent injunctions against both defendants, and permanent officer and director and penny stock bars against Findley. I. Findings of Fact The parties agree that I may make independent findings of fact that are consistent with the jury’s verdict in support of its decision on appropriate remedial sanctions. A. The Jury Found That The Defendants Made Two Categories of False and Misleading Statements with Scienter, and a Third Negligently.

The Commission’s complaint charged Findley and Halitron with violations of Section 17(a) of the Securities Act and Section 10(b) and Rule 10b-5 of the Exchange Act arising out of a series of press releases about Halitron’s business and prospects. See generally Doc. No. 1. After a seven-day trial, the jury found Findley and Halitron liable for fraudulent misrepresentations about the status of Halitron’s financial audit (seven press releases) and its stock buyback program (six press releases) (in violation of Section 17(a)(2) of the Securities Act, Section 10(b) of the Exchange Act and Rule 10b-5(b) thereunder) and about a $3 million promissory note from Life’s Time Capsule (“LTCP”) (in violation of Securities Act Section 17(a)(2)). Doc. No. 133. The jury was instructed that, to find Findley liable for fraudulent misrepresentations, it had to unanimously find that Findley acted with scienter—i.e., an intent to mislead or a high degree of recklessness—for Section 10(b) of the Exchange Act, and, with respect to Securities Act Section 17(a)(2), at least negligently. Doc. No. 132. The jury found that Findley acted with scienter with respect to the statements about the audit and the buyback. Doc. No. 133. However, the jury was not asked to determine on a statement-by-statement basis which of the seven audit press releases and six stock buyback press releases were false and misleading.1 As set forth in the following

section, I find that each of Findley’s statements about the audit and stock buyback was false and misleading and made with scienter.

1 Because the jury found that Findley acted negligently with respect to a single press release concerning a purported $3 million promissory note, I need not engage in a statement-by-statement B. Findley’s Fraudulent Conduct Spanned the Period from May 2017 through April 2018 i. Each of the Six Press Releases Concerning the Stock Buyback Program Was Misleading Between October 30, 2017 and April 25, 2018, Halitron issued six press releases concerning a stock buyback program. Trial Exs. 514, 516, 522-525. Findley authored and had the final say on all six press releases. Trial Tr. 77:14-19; 176:22-24. All the press releases concerning the stock buyback program effectively said the same thing—that Halitron was engaged in a program to buy back Halitron shares in the open market. See Trial Ex. 514, Oct. 30, 2017 (“engaging in a stock buyback program”); Trial Ex. 516, Nov. 10, 2017 (“[positive cash flow] will be utilized to buy back shares”); Trial Ex. 522, Jan. 22, 2018 (“Halitron has begun to buy back shares”); Trial Ex. 523, Feb. 6, 2018 (“the Company will continue to buy back shares”); Ex. 524, Feb. 28, 2018 (“Management has begun to and is committed to acquiring additional

shares”); Trial Ex. 525, April 25, 2018 (“currently engaged in a share buyback program”). The purpose of the stock buyback program was to increase shareholder value (Trial Tr. 83:21-25), and four of the six press releases concerning the buyback specifically stated as much. See Trial Ex. 514, Oct. 30, 2017 (“increase shareholder value by engaging in a stock buyback program”); Trial Ex. 522, Jan. 22, 2018 (“Halitron has begun to buy back shares . . . with the objective to increase its share price”); Trial Ex. 524, Feb. 28, 2018 (“acquiring additional shares back . . . to help support an increase in share price”); Trial Ex. 525, April 25, 2018 (“currently engaged in a share buyback program to help support increased share price”). Ultimately, Halitron bought back shares on only four occasions—in December 2017,

January 2018, and June and July 2018—and spent only $3,500 to buy back less than 15 million shares—“an extremely small percentage” of the number of shares outstanding. See Trial Ex. 129; Trial Tr. 94:25-95:5, 98:21-22 (Findley). However, none of the six press releases disclosed the number of shares Halitron bought back or the small dollar amount Halitron spent on the buyback. See Trial Exs. 514, 516, 522-525; Trial Tr. 88-91. During the same period that Halitron was touting a stock buyback program to increase shareholder value, October 2017 to April 2018, Halitron was issuing billions of discounted shares to various debt financiers. See Trial Ex. 129; Trial Tr. 95:6-12. Findley acknowledged at trial that issuing shares in those amounts dilutes Halitron’s stock—that is, by increasing the number of shares outstanding, it makes each share less valuable. Trial Tr. 100:4- 103:10; Trial Ex. 557 (2016 email from Findley saying “On the pink sheets, you could destroy a company value by

releasing too many shares at once.”) Further, Halitron’s outside counsel specifically warned against the very claim—that the purported buyback program would increase shareholder value— that Findley repeatedly included in press releases: “Can’t say you’ll drive or increase shareholder value (meaning the share price would increase) as the [debt financing transaction] is dilutive and will decrease shareholder value by its very nature.” Trial Ex. 597 at 1. Findley thus knew and was on notice from his counsel that his claims about the stock buyback were misleading. Nevertheless, none of the six press releases concerning the stock buyback program disclosed the billions of discounted shares issued to debt financiers or even that any shares were issued at all. See Trial Exs. 128, 514, 516, 522-525; Trial Tr. 97:16-19.

ii. Each of the Seven Press Releases Concerning the Audit Was False or Misleading

Between May 12, 2017 and April 25, 2018, Halitron issued seven press releases concerning a financial audit of Halitron by auditing firm Friedman LLP. Trial Exs. 509-511, 518, 522, 524, 525. Findley authored and had the final say on all seven press releases. Trial Tr. 176:22-24.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Federal Trade Commission v. Bronson Partners, LLC
654 F.3d 359 (Second Circuit, 2011)
Securities & Exchange Commission v. Razmilovic
738 F.3d 14 (Second Circuit, 2013)
Securities & Exchange Commission v. Moran
944 F. Supp. 286 (S.D. New York, 1996)
Securities & Exchange Commission v. Haligiannis
470 F. Supp. 2d 373 (S.D. New York, 2007)
S.E.C. v. Rajaratnam
918 F.3d 36 (Second Circuit, 2019)
Liu v. SEC. & Exch. Comm'n
591 U.S. 71 (Supreme Court, 2020)
Securities & Exchange Commission v. Kern
425 F.3d 143 (Second Circuit, 2005)
SEC v. Ahmed
72 F.4th 379 (Second Circuit, 2023)
SEC v. Govil
86 F.4th 89 (Second Circuit, 2023)

Cite This Page — Counsel Stack

Bluebook (online)
United States Securities and Exchange Commission v. Findley, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-securities-and-exchange-commission-v-findley-ctd-2024.